|
Jeff Courtney is General Partner at VenGrowth Private Equity Partners Inc. Prior to joining VenGrowth, he was a Partner and Co-President of the Scientific Advisory Board at CDP Capital - Technology Ventures (formerly CDP Sofinov), where he was involved in leading investments in life science companies in Canada and the United States. Mr. Courtney also served as President of Hospital Pharmaceuticals at Faulding Canada Inc., EVP Marketing and Sales for Pharmascience Inc., as well as 11 years of numerous senior leadership roles with Johnson & Johnson Medical Products. He has served as a director on the board of multiple Canadian and U.S. life science companies, and is currently an active board member of VisualSonics Inc., Axela Biosensors Inc., Zelos Therapeutics, Metrigenix, Kadmus Pharmaceuticals, Activbiotics, Interface Biologics, and Targanta Therapeutics. He holds a Bachelor of Science in Microbiology from the University of Guelph. | 